CLINICAL_TRIALS ClinicalTrials.gov record update

Expanded Access Program for United States of America: TAK-881 Subcutaneous for the Treatment of Primary Immunodeficiency Diseases (PIDD)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06955793
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:50.841056+00:00
Published At: 2025-05-02T00:00:00+00:00
Record Updated At: 2025-05-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Primary Immunodeficiency Diseases (PIDD)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-05-02"
protocolSection.identificationModule.nctId: "NCT06955793"
protocolSection.identificationModule.officialTitle: "Expanded Access Program for United States of America: TAK-881 Subcutaneous for the Treatment of Primary Immunodeficiency Diseases (PIDD)"
protocolSection.statusModule.overallStatus: "AVAILABLE"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.